Can a TB vaccine be upgraded to fight RSV in seniors?
⭐️ VACCINE ⭐️
Not yet recruiting
This trial is testing a new vaccine called rBCG-N-RSV, which is based on the BCG vaccine (used for tuberculosis) but modified to also target respiratory syncytial virus (RSV). The study involves 200 adults over 60 years old, who will receive either this new vaccine or the standar…
Phase: PHASE2 • Sponsor: Biothervax SpA • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 15, 2026 00:00 UTC